Arbor Rapha Capital Bioholdings I (ARCK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ARCK Annual Balance Sheets →
This balance sheet overview for Arbor Rapha Capital Bioholdings I spans from Sep 30 2021 to Sep 30 2022, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent0.88
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.39
Total Current Assets1.28
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR0.03
Other Assets, Noncurrent177.87
Total Assets179.18
Liabilities
Other Liabilities, Current0.77
Total Current Liabilities0.77
Total Long-term Debt0.00
Other liabilities, Noncurrent10.35
Accrued Formation Costs0.77
Accrued Offering Costs0.00
Deferred Offering Costs Noncurrent6.04
Total Liabilities11.12
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock0.00
Retained Earnings / Accumulated Deficit-9.34
Other Equity-177.40
Common Stockholder's Equity-186.74
Non-controlling interests & other177.40
Total Stockholder's Equity-9.34
Liabilities & Stockholder's Equity179.18
4 historic quarters locked

Sign in to unlock the full Arbor Rapha Capital Bioholdings I balance sheet history.

About Arbor Rapha Capital Bioholdings Corp I Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-22-117282

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.